Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
Xinyi Shen, Lihua Li, Zhen Sun, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Pathophysiology of Atherosclerosis
Shifa Jebari‐Benslaiman, Unai Galicia-García, Asier Larrea‐Sebal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3346-3346
Open Access | Times Cited: 535
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 144
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Ahmad Al Samarraie, Maxime Pichette, Guy Rousseau
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5420-5420
Open Access | Times Cited: 40
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Xiaofeng Chen, Hua Zhang, Sichong Ren, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 19, pp. 2269-2284
Open Access | Times Cited: 33
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
Fecal bacteria transplantation replicates aerobic exercise to reshape the gut microbiota in mice to inhibit high-fat diet-induced atherosclerosis
Jie Men, Hao Li, Chenbin Cui, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0314698-e0314698
Open Access | Times Cited: 1
MAIT Cells Promote Cholesterol Excretion Pathways Mitigating Atherosclerosis
Hua Wang, Pukar KC, Kaidi Zhang, et al.
Circulation Research (2025)
Closed Access | Times Cited: 1
The role of microbiota in nonalcoholic fatty liver disease
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
Roles of Trimethylamine-N-oxide in Atherosclerosis and Its Potential Therapeutic Aspect: A Literature Review
Yudi Her Oktaviono, Ariikah Dyah Lamara, Pandit Bagus Tri Saputra, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 20
The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
Racha El Hage, Nada Al-Arawe, Irene Hinterseher
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2399-2399
Open Access | Times Cited: 19
Two-sample Mendelian randomization to study the causal association between gut microbiota and atherosclerosis
Shijiu Jiang, Cheng Yu, Bingjie Lv, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review
Mahmoud Yousef, Mlaak Rob, Sanish Varghese, et al.
Life Sciences (2024) Vol. 342, pp. 122535-122535
Open Access | Times Cited: 7
Research development on gut microbiota and vulnerable atherosclerotic plaque
Shujiao Zheng, Zuheng Liu, Haiyue Liu, et al.
Heliyon (2024), pp. e25186-e25186
Open Access | Times Cited: 6
Gut microbiome and metabolomic profiles reveal the antiatherosclerotic effect of indole-3-carbinol in high-choline-fed ApoE-/- mice
Yuan He, Ying Zhu, Xiaorong Shui, et al.
Phytomedicine (2024) Vol. 129, pp. 155621-155621
Open Access | Times Cited: 6
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
Roxana Mihaela Chiorescu, Mihaela Mocan, Andreea-Ioana Inceu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13638-13638
Open Access | Times Cited: 26
Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats
Shuai Dong, Qi Liu, Xue Zhou, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 612-612
Open Access | Times Cited: 15
Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease
Yinuo Wen, Zefan Sun, Shuoyin Xie, et al.
Journal of Multidisciplinary Healthcare (2022) Vol. Volume 15, pp. 2591-2603
Open Access | Times Cited: 19
Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review
José Patrocínio Ribeiro Cruz Neto, Micaelle Oliveira de Luna Freire, Deborah Emanuelle de Albuquerque Lemos, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2886-2886
Open Access | Times Cited: 4
Artificial Intelligence-Based Target for Personalized Interventions of Atherosclerosis from Gut Microbiota Signature
Suravi Majumder, Koushik Sen, Rabimba Karanjai
SynBio (2025) Vol. 3, Iss. 1, pp. 2-2
Open Access
Antiinflammatory effects of postbiotics
Megha J.K., Lokesh Ravi
Elsevier eBooks (2025), pp. 491-511
Closed Access
Lipid metabolism correction with statins and probiotics
Н. В. Барышникова, V. M. L’Nyavina, Yury P. Uspenskiy, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 161-174
Closed Access
Key parameters for designing robust 2D and 3D spheroid models for in vitro atherosclerosis research
Ibukunoluwa Naiyeju, Stéphanie Lehoux, Maryam Tabrizian
Bioengineering & Translational Medicine (2025)
Open Access
Effects of pumpkin and fermented whey on fecal microbiota profile against AFB1 and OTA exposure in Wistar rats
Álvaro Lázaro, Pilar Gómez‐Ramírez, Pilar Vila‐Donat, et al.
Toxicology Mechanisms and Methods (2025), pp. 1-18
Closed Access
Diagnostic significance of the gut microbiota and its metabolites in cardiovascular risk assessment among patients with ulcerative colitis
Galiya R. Bicbavova, М. А. Ливзан, Д. В. Турчанинов, et al.
Russian Journal of Evidence-Based Gastroenterology (2025) Vol. 14, Iss. 1, pp. 39-39
Closed Access
Plasma Lipidomics, Gut Microbiota Profile, and Phenotype of Adipose Tissue in an ApoE-/- Mouse Model of Plaque Instability
Guanlin Yang, Xin Tan, Qiuyu Zhai, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top